Clarity Pharmaceuticals Investor Relations Material

Clarity Pharmaceuticals Ltd is a radiopharmaceutical company specializing in the development of targeted theranostic products for the diagnosis and treatment of serious diseases, particularly cancer. Utilizing its proprietary platform technology, the company develops products that combine diagnostic imaging and therapeutic capabilities, allowing for precise targeting of cancer cells with minimal impact on surrounding healthy tissues. The company is headquartered in Sydney, Australia, and its shares are listed on the Australian Securities Exchange.